Cargando…
Midbrain Dopaminergic Neuron Development at the Single Cell Level: In vivo and in Stem Cells
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that predominantly affects dopaminergic (DA) neurons of the substantia nigra. Current treatment options for PD are symptomatic and typically involve the replacement of DA neurotransmission by DA drugs, which relieve the patients of...
Autores principales: | Ásgrímsdóttir, Emilía Sif, Arenas, Ernest |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357704/ https://www.ncbi.nlm.nih.gov/pubmed/32733875 http://dx.doi.org/10.3389/fcell.2020.00463 |
Ejemplares similares
-
A protocol for the differentiation of human embryonic stem cells into midbrain dopaminergic neurons
por: Nishimura, Kaneyasu, et al.
Publicado: (2023) -
Cryopreservation of Human Midbrain Dopaminergic Neural Progenitor Cells Poised for Neuronal Differentiation
por: Drummond, Nicola J., et al.
Publicado: (2020) -
Sevoflurane promotes premature differentiation of dopaminergic neurons in hiPSC-derived midbrain organoids
por: Shang, Jia, et al.
Publicado: (2022) -
The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
por: Minakaki, Georgia, et al.
Publicado: (2020) -
Dose-Dependent and Subset-Specific Regulation of Midbrain Dopaminergic Neuron Differentiation by LEF1-Mediated WNT1/b-Catenin Signaling
por: Nouri, Parivash, et al.
Publicado: (2020)